Category: Biosimilars
Biosimilars market research reports by Icon Group International, Inc.
-
The 2023-2028 World Outlook for Biosimilar Drugs
The 2023-2028 World Outlook for Biosimilar Drugs This study covers the world outlook for biosimilar drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2023-2028 World Outlook for Biosimilars and Follow-on Biologics
The 2023-2028 World Outlook for Biosimilars and Follow-on Biologics This study covers the world outlook for biosimilars and follow-on biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies (mAb) This study covers the world outlook for biosimilar monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies This study covers the world outlook for biosimilar monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2023-2028 World Outlook for Erythropoietin Drugs
The 2023-2028 World Outlook for Erythropoietin Drugs This study covers the world outlook for erythropoietin drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
Research Assistance
